Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 1,176.56 million compared to CNY 883.05 million a year ago. Revenue was CNY 1,176.56 million compared to CNY 883.05 million a year ago. Net income was CNY 330.09 million compared to CNY 272.9 million a year ago. Basic earnings per share from continuing operations was CNY 0.2077 compared to CNY 0.1692 a year ago. Diluted earnings per share from continuing operations was CNY 0.2077 compared to CNY 0.1692 a year ago.